NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).
*Cover photo painting by Diane Fairfield
Company Details
- Employees
- 13
- Founded
- -
- Address
- 1635 E 18th St, Tucson,arizona 85719,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.nuvoxpharma.com
- HQ
- Tucson, Arizona
Nuvox Therapeutics Questions
Nuvox Therapeutics's website is http://www.nuvoxpharma.com
Nuvox Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nuvox-therapeutics
Nuvox Therapeutics has
13 employees.
View email and phone details for 13
employees at Nuvox Therapeutics.
Nuvox Therapeutics's industry is
Pharmaceutical Manufacturing
Nuvox Therapeutics's top competitors are
Theracea Pharma,
Think Bioscience,
Onconaut Therapeutics Inc.,
Nuvox Healthcare Pvt Ltd,
Reglagene,
Trampoline Pharma, Inc.,
Darwin Biosciences,
Metfora Diagnostics,
Microvascular Therapeutics,
Photonpharma.
Nuvox Therapeutics's categories are Pharmaceutical Manufacturing
Nuvox Therapeutics's founding year is 2008
